132 related articles for article (PubMed ID: 11673296)
1. Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.
Boyd S; Owens D; Gin T; Bunce K; Sherafat H; Perry D; Hykin PG
Br J Ophthalmol; 2001 Nov; 85(11):1313-5. PubMed ID: 11673296
[TBL] [Abstract][Full Text] [Related]
2. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
3. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.
Koylu MT; Kucukevcilioglu M; Erdurman FC; Durukan AH; Sobacı G; Torun D; Tunca Y; Ayyildiz O
Ophthalmic Genet; 2017; 38(4):352-356. PubMed ID: 28085519
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.
Dong N; Xu B; Tang X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4057-62. PubMed ID: 24906854
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
7. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
[TBL] [Abstract][Full Text] [Related]
8. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.
McGimpsey SJ; Woodside JV; Bamford L; Gilchrist SE; Graydon R; McKeeman GC; Young IS; Hughes AE; Patterson CC; O'Reilly D; McGibbon D; Chakravarthy U
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4712-6. PubMed ID: 16303969
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilia in patients with retinal vein occlusion: a retrospective analysis.
Risse F; Frank RD; Weinberger AW
Ophthalmologica; 2014; 232(1):46-52. PubMed ID: 24853960
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine levels, methylene tetrahydrofolate reductase A1298C gene polymorphism and risk of retinal vein thrombosis.
Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):679-83. PubMed ID: 26650461
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia in central retinal vein occlusion in young adults.
Parodi MB; Di Crecchio L
Semin Ophthalmol; 2003 Sep; 18(3):154-9. PubMed ID: 15513477
[TBL] [Abstract][Full Text] [Related]
13. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
14. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
McGimpsey SJ; Woodside JV; Cardwell C; Cahill M; Chakravarthy U
Ophthalmology; 2009 Sep; 116(9):1778-1787.e1. PubMed ID: 19729099
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.
Li D; Zhou M; Peng X; Sun H
BMC Ophthalmol; 2014 Nov; 14():147. PubMed ID: 25428529
[TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
18. Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections.
Konrad C; Müller GA; Langer C; Kuhlenbäumer G; Berger K; Nabavi DG; Dziewas R; Stögbauer F; Ringelstein EB; Junker R
J Neurol; 2004 Oct; 251(10):1242-8. PubMed ID: 15503105
[TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine in patients with retinal vein occlusion.
Minniti G; Calevo MG; Giannattasio A; Camicione P; Armani U; Lorini R; Piana G
Eur J Ophthalmol; 2014; 24(5):735-43. PubMed ID: 24519513
[TBL] [Abstract][Full Text] [Related]
20. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
